Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis.

It has been suggested that the cAMP responsive element-binding protein (CREB) may act as a transcription regulator of aromatase in breast cancer cells. However, there is little knowledge on the expression of CREB1 in human breast cancer and its clinical significance. The current study investigated the expression pattern of CREB1 in human breast cancer at the mRNA and protein level and correlated it with the clinical outcome. CREB1 staining was primarily seen in the nucleus of both normal and tumour cells. At the mRNA level, we found a significantly higher level of CREB1 in breast tumour tissues (n=120) as compared to non-neoplastic mammary tissues (n=33, p=0.0092). When compared between different histological types CREB1 expression was significantly higher in ductal carcinoma as compared to lobular and other breast carcinoma. Patients with a poor prognosis and with metastasis had a markedly raised level of CREB1 compared to patients who were disease free. In addition, node-positive tumours had higher levels of CREB1 than node-negative tumours (p=0.0018). Finally, patients with high levels of CREB1 had a significantly shorter disease-free survival [95.3 (68.4-122.3, 95% CI) months] compared with those with lower levels [133.9 (123.5-144.2) months, p=0.0193]. This study demonstrates that the level of CREB1 in breast cancer patients is elevated and is significantly raised in patients with a poor prognosis, metastatic disease and nodal involvement. We conclude that the level of CREB1 expression is aberrant in human breast cancer and is associated with disease progression in breast cancer patients.

[1]  M. Reed,et al.  Aromatase activity in normal breast and breast tumor tissues: In vivo and in vitro studies , 1987, Steroids.

[2]  M. Montminy,et al.  Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene , 1987, Nature.

[3]  J. Jameson,et al.  Structural determinants for transcriptional activation by cAMP-responsive DNA elements. , 1988, The Journal of biological chemistry.

[4]  Shiuan Chen,et al.  Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation. , 1992, The American journal of pathology.

[5]  N. Harada,et al.  Stromal spindle cells contain aromatase in human breast tumors. , 1994, The Journal of clinical endocrinology and metabolism.

[6]  G. Chetrite,et al.  Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. , 1996, The Journal of clinical endocrinology and metabolism.

[7]  S. Wilczynski,et al.  Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  Shiuan Chen,et al.  Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  I. Nazarenko,et al.  A closed tube format for amplification and detection of DNA based on energy transfer. , 1997, Nucleic acids research.

[10]  D. Zhou,et al.  Identification and characterization of a cAMP-responsive element in the region upstream from promoter 1.3 of the human aromatase gene. , 1999, Archives of biochemistry and biophysics.

[11]  W. Jiang,et al.  Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells. , 2000, The Journal of urology.

[12]  T. Kerppola,et al.  Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity , 2001, Oncogene.

[13]  Shiuan Chen,et al.  Transcriptional regulation of aromatase expression in human breast tissue , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  P. Vitti,et al.  Expression of cAMP response element-binding protein and sodium iodide symporter in benign non-functioning and malignant thyroid tumours. , 2003, European journal of endocrinology.

[15]  E. Simpson,et al.  Role of CRE-Binding Protein (CREB) in Aromatase Expression in Breast Adipose , 2003, Breast Cancer Research and Treatment.

[16]  U. Moens,et al.  What turns CREB on? , 2004, Cellular signalling.

[17]  H. Soreq,et al.  CREB regulates AChE-R-induced proliferation of human glioblastoma cells. , 2004, Neoplasia.

[18]  G. Watkins,et al.  Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. , 2004, Endocrine-related cancer.

[19]  Troy Stevens,et al.  Open Access Activated Leukocyte Cell Adhesion Molecule in Breast Cancer: Prognostic Indicator , 2022 .

[20]  F. Kaye,et al.  Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. , 2005, Cancer research.

[21]  R. Kvetňanský,et al.  Stress Triggered Changes in Gene Expression in Adrenal Medulla: Transcriptional Responses to Acute and Chronic Stress , 2006, Cellular and Molecular Neurobiology.

[22]  H. Aonuma,et al.  De Novo synthesis of CREB in a presynaptic neuron is required for synaptic enhancement involved in memory consolidation , 2006, Journal of neuroscience research.

[23]  M. Ellis,et al.  Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-Analysis , 2007 .